ArticleNeuro-oncology advances

Relation between tumor treating fields usage rate ≥75% for the first 3 months and progression-free survival in patients with newly diagnosed WHO grade 4 gliomas.

Shoichi Deguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.